Recombinant Expression of Caveolin-1 in Oncogenically Transformed Cells Abrogates Anchorage-independent Growth
Jeffrey A. Engelman(Whitehead Institute for Biomedical Research), Charles C. Wykoff(Whitehead Institute for Biomedical Research), Shingo Yasuhara(Cleveland Clinic), Kenneth Song(Whitehead Institute for Biomedical Research), Takashi Okamoto(Cleveland Clinic), Michael P. Lisanti(Whitehead Institute for Biomedical Research)
Cited by 370Open Access
Abstract
Caveolae are plasma membrane-attached vesicular organelles. Caveolin-1, a 21-24-kDa integral membrane protein, is a principal component of caveolae membranes in vivo. Both caveolae and caveolin are most abundantly expressed in terminally differentiated cells: adipocytes, endothelial cells, and muscle cells. Conversely, caveolin-1 mRNA and protein expression are lost or reduced during cell transformation by activated oncogenes such as v-abl and H-ras (G12V); caveolae are absent from these cell lines. However, its remains unknown whether down-regulation of caveolin-1 protein and caveolae organelles contributes to their transformed phenotype.
Related Papers
No related papers found
Powered by citation graph analysis